back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-04-01 09:19 Tx date 2025-03-31 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$21,307
+1,911 vol $11.15 each |
47,745 | |
| Filed 2025-04-01 09:16 Tx date 2025-03-31 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
-3,823 vol |
45,834 | |
| Filed 2025-03-19 13:51 Tx date 2025-03-18 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
+3,273 vol |
49,657 | |
| Filed 2025-03-11 10:56 Tx date 2024-12-31 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$2,024
+229 vol $8.84 each |
46,384 | |
| Filed 2025-03-11 10:53 Tx date 2024-12-31 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$10,105
+1,045 vol $9.67 each |
46,155 | |
| Filed 2024-12-16 15:29 Tx date 2024-12-16 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-6,394.64
-532 vol $12.02 each |
45,110 | |
| Filed 2024-12-16 15:28 Tx date 2024-12-16 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$5,836
+532 vol $10.97 each |
45,642 | |
| Filed 2024-12-16 15:26 Tx date 2024-12-16 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares - Options
51 - Exercise of options
|
$-5,836.04
-532 vol $10.97 each |
0 | |
| Filed 2024-12-16 15:24 Tx date 2024-12-16 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,432.76
-119 vol $12.04 each |
45,110 | |
| Filed 2024-12-16 15:21 Tx date 2024-12-12 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-3,594
-300 vol $11.98 each |
45,229 | |
| Filed 2024-09-23 11:34 Tx date 2024-09-20 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-27,473.55
-2,509 vol $10.95 each |
45,529 | |
| Filed 2024-09-23 11:16 Tx date 2024-09-20 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares - Options
51 - Exercise of options
|
$-22,272
-2,320 vol $9.60 each |
3,516 | |
| Filed 2024-09-23 11:11 Tx date 2024-09-20 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-32,674.80
-2,984 vol $10.95 each |
48,038 | |
| Filed 2024-09-23 11:10 Tx date 2024-09-20 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$24,528
+2,984 vol $8.22 each |
51,022 | |
| Filed 2024-09-23 11:07 Tx date 2024-09-20 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares - Options
51 - Exercise of options
|
$-24,528.48
-2,984 vol $8.22 each |
532 | |
| Filed 2024-09-23 11:01 Tx date 2024-09-20 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-25,404
-2,320 vol $10.95 each |
48,038 | |
| Filed 2024-09-23 11:00 Tx date 2024-09-20 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$22,272
+2,320 vol $9.60 each |
50,358 | |
| Filed 2024-09-23 10:57 Tx date 2024-09-20 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares - Options
51 - Exercise of options
|
$-22,656
-2,360 vol $9.60 each |
3,476 | |
| Filed 2024-09-23 10:57 Tx date 2024-09-20 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares - Options
51 - Exercise of options
|
$-22,656
-2,360 vol $9.60 each |
||
| Filed 2024-03-28 09:33 Tx date 2024-03-27 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
+4,074 vol |
48,038 | |
| Filed 2024-03-25 13:07 Tx date 2023-12-31 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$2,166
+281 vol $7.71 each |
46,233 | |
| Filed 2024-03-25 13:04 Tx date 2023-12-31 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$18,088
+2,337 vol $7.74 each |
45,952 | |
| Filed 2024-03-21 14:10 Tx date 2024-03-19 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$19,278
+2,268 vol $8.50 each |
41,346 | |
| Filed 2024-03-21 14:05 Tx date 2024-03-19 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
-4,537 vol |
39,078 | |
| Filed 2023-12-08 17:09 Tx date 2023-12-08 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-49,300
-5,800 vol $8.50 each |
43,615 | |
| Filed 2023-12-08 17:08 Tx date 2023-12-06 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-70,958
-8,348 vol $8.50 each |
49,415 | |
| Filed 2023-12-08 17:07 Tx date 2023-12-06 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$20,300
+2,762 vol $7.35 each |
57,763 | |
| Filed 2023-12-08 17:06 Tx date 2023-12-06 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$12,443
+2,007 vol $6.20 each |
55,001 | |
| Filed 2023-12-08 17:05 Tx date 2023-12-06 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares - Options
51 - Exercise of options
|
$-20,300.70
-2,762 vol $7.35 each |
5,836 | |
| Filed 2023-12-08 17:04 Tx date 2023-12-06 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares - Options
51 - Exercise of options
|
$-12,443.40
-2,007 vol $6.20 each |
8,598 | |
| Filed 2023-12-08 17:02 Tx date 2023-12-06 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$26,663
+3,579 vol $7.45 each |
52,994 | |
| Filed 2023-12-08 16:59 Tx date 2023-12-06 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares - Options
51 - Exercise of options
|
$26,663
+3,579 vol $7.45 each |
14,184 | |
| Filed 2023-12-08 16:59 Tx date 2023-12-06 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares - Options
51 - Exercise of options
|
$26,663
+3,579 vol $7.45 each |
||
| Filed 2023-12-08 16:58 Tx date 2023-12-06 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares - Options
51 - Exercise of options
|
$-26,663.55
-3,579 vol $7.45 each |
10,605 | |
| Filed 2023-11-29 14:50 Tx date 2023-11-27 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-8,500
-1,000 vol $8.50 each |
49,415 | |
| Filed 2023-11-29 14:49 Tx date 2023-11-27 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$7,450
+1,000 vol $7.45 each |
50,415 | |
| Filed 2023-11-29 14:47 Tx date 2023-11-27 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares - Options
51 - Exercise of options
|
$-7,450
-1,000 vol $7.45 each |
14,184 | |
| Filed 2023-04-03 11:18 Tx date 2023-03-31 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
+4,587 vol |
49,415 | |
| Filed 2023-03-31 17:02 Tx date 2023-03-31 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$29,040
+3,872 vol $7.50 each |
44,828 | |
| Filed 2023-03-31 16:59 Tx date 2023-03-31 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
-7,744 vol |
40,956 | |
| Filed 2023-03-13 16:50 Tx date 2022-12-31 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$627.45
+89 vol $7.05 each |
48,700 | |
| Filed 2023-03-13 16:45 Tx date 2022-12-31 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$15,838
+1,953 vol $8.11 each |
48,611 | |
| Filed 2022-04-01 11:58 Tx date 2022-03-31 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
$33,096
+3,641 vol $9.09 each |
46,658 | |
| Filed 2022-03-14 11:21 Tx date 2021-12-31 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$11,364
+1,474 vol $7.71 each |
43,017 | |
| Filed 2021-03-19 19:50 Tx date 2021-03-19 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
$32,083
+4,395 vol $7.30 each |
41,543 | |
| Filed 2021-03-11 17:05 Tx date 2020-12-31 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$2,600
+516 vol $5.04 each |
37,148 | |
| Filed 2020-04-02 12:23 Tx date 2020-03-31 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
$27,648
+7,659 vol $3.61 each |
36,632 | |
| Filed 2020-03-24 11:19 Tx date 2020-03-23 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$63,525
+18,150 vol $3.50 each |
28,973 | |
| Filed 2020-03-02 10:53 Tx date 2019-12-31 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$7,501
+1,022 vol $7.34 each |
10,823 | |
| Filed 2019-03-22 Tx date 2019-03-19 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares - Options
50 - Grant of options
|
$24,528
+2,984 vol $8.22 each |
15,184 | |
| Filed 2019-03-04 Tx date 2018-12-31 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$7,147
+750 vol $9.53 each |
9,801 | |
| Filed 2018-03-26 Tx date 2017-12-31 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$6,648
+742 vol $8.96 each |
9,051 | |
| Filed 2018-01-11 Tx date 2018-01-08 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares - Options
50 - Grant of options
|
$22,272
+2,320 vol $9.60 each |
12,200 | |
| Filed 2017-07-04 Tx date 2017-07-04 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$66,498
+8,309 vol $8.00 each |
8,309 | |
| Filed 2017-07-04 Tx date 2016-02-12 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-03-15 Tx date 2017-03-15 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares - Options
50 - Grant of options
|
$20,300
+2,762 vol $7.35 each |
9,880 | |
| Filed 2016-02-25 Tx date 2016-02-12 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares - Options
50 - Grant of options
|
$12,443
+2,007 vol $6.20 each |
7,118 | |
| Filed 2016-02-25 Tx date 2016-02-12 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares - Options
00 - Opening Balance-Initial SEDI Report
|
5,111 |